• Agilent launched a Gen5 AI Cell Identification Module to add AI-based cell identification and segmentation to BioTek Gen5 imaging workflows.
• Software targets compatible BioTek Cytation and Lionheart automated imagers, aiming to cut manual steps in cell counting and confluence analysis.
• AI segmentation removes conventional threshold setting or parameter tuning, a source of user-driven variability in high-throughput image analysis.
• Module supports label-free or fluorescence assays, including live-cell or kinetic formats used in life science and drug research.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609290800BIZWIRE_USPR_____20260929_BW497412) on September 29, 2026, and is solely responsible for the information contained therein.